Clinical Trial Update: Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating vaccination with autologous dendritic cells loaded with autologous tumor homogenate in glioblast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Autologous dendritic cell vaccine loaded with autologous tumor homogenate

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Glioblastoma, Vaccination | Phase 2 | Status: RECRUITING